| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18544744 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 121 journal articles in the PubMed database | Email to a friend | | |
| Grady D, Cauley JA, Geiger MJ, et al.
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. [Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
J Natl Cancer Inst 2008 Jun 18; 100(12):854-61.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Martino S, Cauley JA, Barrett-Connor E, et al.
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Natl Cancer Inst 2004 Dec 1; 96(23):1751-61.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Burshell AL, Song J, Dowsett SA, et al.
Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis. [JOURNAL ARTICLE]
Curr Med Res Opin 2008 Feb 5.
Abstract | Full Citation | Find Related Articles | | Lippman ME, Cummings SR, Disch DP, et al.
Effect of Raloxifene on the Incidence of Invasive Breast Cancer in Postmenopausal Women with Osteoporosis Categorized by Breast Cancer Risk. [JOURNAL ARTICLE]
Clin Cancer Res 2006 Sep 1; 12(17):5242-5247.
Abstract | Full Citation | Find Related Articles | | Cauley JA, Norton L, Lippman ME, et al.
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Breast Cancer Res Treat 2001 Jan; 65(2):125-34.
Abstract | Full Citation | Find Related Articles | | Barrett-Connor E, Mosca L, Collins P, et al.
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. [Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2006 Jul 13; 355(2):125-37.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Vogel VG, Costantino JP, Wickerham DL, et al.
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. [Journal Article, Multicenter Study, Randomized Controlled Trial]
JAMA 2006 Jun 21; 295(23):2727-41.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Johnell O, Cauley JA, Kulkarni PM, et al.
Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapy. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Fam Pract 2004 Oct; 53(10):789-96.
Abstract | Full Citation | Find Related Articles | | Lippman ME, Krueger KA, Eckert S, et al.
Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Oncol 2001 Jun 15; 19(12):3111-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
